The Latest Breaking News from diabetes

If You Take Ozempic, Wegovy, or Zepbound, Your Risk of Heat Illness Is Higher This Summer

GLP-1 drugs like Ozempic and Wegovy suppress thirst, raising dehydration risk in heat. Doctors say patients must hydrate proactively. Here's the specific clinical warning for summer.

Medical Daily · Jul 6

Indian scientists recreate key human placenta functions on a chip

Indian researchers have unveiled a groundbreaking "placenta-on-chip" technology, a lab-grown model replicating crucial functions of the human placenta. This innovative platform, developed by ICMR-NIRWoH and IIT Bombay, promises to unravel mysteries surrounding pregnancy, aid in understanding complications like gestational diabetes, and evaluate drug safety, potentially reducing reliance on animal testing.…

The Economic Times · Jul 4

Study Finds Dementia Risk Factors Hit Women Harder – High Blood Pressure, BMI and Hearing Loss Are Key

As researchers continue searching for ways to reduce dementia risk, a new study is shedding light on why women may face a greater burden than men. Scientists found that several well-known risk factors—including high blood pressure, elevated body mass index (BMI), hearing loss, and diabetes—appear to have a stronger negative…

Budget and the Bees · Jul 3

June Brought Two Major FDA Advances for Children with Type 1 Diabetes: Here's What Each One Does

June 2026 brought two FDA milestones for pediatric diabetes: an OTC kids' CGM and teplizumab for Stage 3 Type 1 diabetes in ages 8–17. Here's what each one does and who qualifies.

Medical Daily · Jun 28

Type 2 diabetes patients often have high blood sugar while fasting – here’s why

Many patients with type 2 diabetes wonder how their blood sugar levels can be high when they have not eaten anything. The answer to this counterintuitive phenomenon lies in what is known as insulin resistance.

The Conversation · Jun 24

UK parents jailed over 12-year-old son's 'entirely preventable' death from untreated diabetes

A teacher couple has been jailed after their 12-year-old son died from undiagnosed diabetes, despite showing severe symptoms hours before his death.

The Times of India · Jun 24

ENDO 2026 Study Finds Most People Who Stop Ozempic or Tirzepatide for Type 2 Diabetes Eventually Restart Treatment

ENDO 2026 research published June 2026 via ScienceDaily found most GLP-1 users with type 2 diabetes who stop treatment eventually restart, driven by weight regain.

Medical Daily · Jun 23

Health company accused of using fake doctors for sales

Australians with diabetes, heart disease, obesity and menopause paid thousands and spoke with fake doctors who said their lives were at risk, a watchdog claims.

AAP · Jun 23

Drug that delays onset of type 1 diabetes approved in England and Wales

Availability of teplizumab on the NHS – which postpones early stages of disease for up to three years – described as an ‘incredible moment’

The Guardian - UK · Jun 23

NHS approves breakthrough drug that can delay type 1 diabetes for years

IN FULL

The Independent UK · Jun 23